Drugs made locally, be it under patent or generic, must be of high and uniform quality. Variations in quality has dogged the domestic pharma sector. Uneven quality of medicines will undermine the Jan Aushadhi scheme geared to making prescription drugs affordable, even as GoI has more than doubled its spend on it. The drug regulatory structure must be overhauled for greater accountability and transparency
